Miguel Escario Gómez

2PUBLICATIONS
1CO-AUTHORS
Other education not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jun 11, 2026
Author response.

|Apr 13, 2026
Effectiveness and safety of first-line nivolumab-ipilimumab in metastatic renal cell carcinoma.

Miguel Escario Gómez, Macarena García-Trevijano Cabetas, Clara Herranz Muñoz

Pageof 1

Frequent Collaborators

1 joint publications

Luis Sánchez Rubio-Ferrández